NCT02554500

Brief Summary

In trauma surgery and hand surgery treatment strategies of none healing bone fractures aim at replacing pseudarthrosis by well vascularized bone and improving microcirculation. Although previous studies indicate that remote ischemic preconditioning (RIPC) can accelerate bone healing in case of non-union, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of remote ischemic preconditioning (RIPC) on scaphoid bones and metacarpal bones and metatarsal bones in a human in-vivo setting for the first time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 18, 2015

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

7.4 years

First QC Date

September 16, 2015

Last Update Submit

February 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in microcirculation (composite outcome measure)

    * Bone blood flow \[arbitrary units AU\] * Bone blood velocity \[AU\] * Tissue oxygen saturation \[%\] * Relative postcapillary venous filling pressure \[AU\] (Composite outcome measure)

    Baseline and 1 minute post-dose

Study Arms (5)

Intact scaphoid bone

EXPERIMENTAL

Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Procedure: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Intact metacarpal bone

EXPERIMENTAL

Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Procedure: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Fractured scaphoid bone

EXPERIMENTAL

Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Procedure: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Fractured metacarpal bone

EXPERIMENTAL

Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Procedure: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Intact metatarsal bone

EXPERIMENTAL

Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metatarsal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Procedure: Remote Ischemic Preconditioning (by Blood Pressure Cuff)

Interventions

Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.

Fractured metacarpal boneFractured scaphoid boneIntact metacarpal boneIntact metatarsal boneIntact scaphoid bone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid bone.
  • Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
  • Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone.
  • Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.

You may not qualify if:

  • below 18 years of age
  • scar tissue above measuring focus
  • osteoporosis or comparable bone disease
  • medication that influences bones

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Schleswig-Holstein

Lübeck, Schleswig-Holstein, 23538, Germany

Location

Study Officials

  • Tobias Kisch, MD

    University Hospital Schleswig-Holstein

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 16, 2015

First Posted

September 18, 2015

Study Start

September 1, 2015

Primary Completion

February 1, 2023

Study Completion

February 1, 2023

Last Updated

February 24, 2023

Record last verified: 2023-02

Locations